2031년까지 글로벌 및 슬로바키아 암 치료제 시장 전망

Global & Slovakia Cancer Therapeutics Market to 2031

상품코드Singapore Cancer Therapeutics Market.pdf
발행기관Business Market Insights
발행일2025.05.26
페이지 수100 Pages
포맷PDF
커버리지Country

₩3,600,000 – ₩6,600,000

보고서 요약(국문)

암은 슬로바키아에서 두 번째로 흔한 사망 원인입니다. 흡연은 여전히 ​​중요한 위험 요인으로, 인구의 21%가 매일 흡연하고 있으며 이는 유럽 평균인 18%보다 높습니다. 또한 슬로바키아의 연간 1인당 알코올 소비량은 10리터로 유럽 연합 평균을 초과합니다. 암 검진율 역시 최적 수준에 미치지 못합니다. 2023-2024년에는 유방암 검진 대상자의 약 25%만이 검진을 받았는데, 이는 일반적인 유럽 국가의 54%에 비해 매우 낮은 수치입니다.

이러한 문제들을 해결하기 위해서는 조기 발견과 예방에 중점을 둔 포괄적인 접근 방식이 필요하며, 이를 위해서는 국가 의료 인프라에 대한 투자 확대가 필수적입니다. 치료 접근성의 불평등을 줄이고 암으로 인한 사회경제적 영향을 완화하기 위해 슬로바키아 암협회(OnkoAlliance Slovakia)와 유럽 암 기구(European Cancer Organisation)는 2023년 슬로바키아 보건부와 협력하여 "정책에서 실행까지 암 검진" 캠페인을 시작했습니다. 정부 주도의 이러한 정책과 암에 대한 인식 제고가 맞물려 예측 기간 동안 암 치료제 수요 증가를 견인할 것으로 예상됩니다.

보고서 요약(영어 원문)

Cancer ranks as the second leading cause of death in Slovakia. Smoking remains a significant risk factor, with 21% of the population smoking daily—higher than the European average of 18%. Additionally, Slovakia’s annual per capita alcohol consumption stands at 10 liters, exceeding the average across the European Union. Cancer screening rates are also below optimal levels; in 2023-2024, only about 25% of the eligible population underwent breast cancer screening, compared to 54% in typical European countries.

Tackling these issues requires a comprehensive approach focused on early detection and prevention, which in turn calls for increased investment in the country’s healthcare infrastructure. To reduce disparities in treatment access and alleviate the socioeconomic impact of cancer, the OnkoAlliance Slovakia and the European Cancer Organisation partnered with Slovakia’s Ministry of Health in 2023 to launch the “Cancer Screening from Policy to Implementation” campaign. This government-led initiative, combined with rising awareness about cancer, is expected to drive increased demand for cancer therapeutics throughout the forecast period.

상세 목차

TABLE OF CONTENTS

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation:

4. Slovakia Cancer Therapeutics Market Landscape

4.1 Overview

4.2 Ecosystem Analysis

4.2.1 List of Vendors in the Value Chain

5. Cancer Therapeutics Market Key Market Dynamics

5.1 Cancer Therapeutics Market – Key Market Dynamics

5.2 Market Drivers

5.3 Market Restraints

5.4 Market Opportunities

5.5 Future Trends

5.6 Impact of Drivers and Restraints

6. Slovakia Cancer Therapeutics Market – Analysis

6.1 Slovakia Cancer Therapeutics Market Revenue (US$ Million), 2021–2031

6.2 Slovakia Cancer Therapeutics Market Revenue and Forecast Analysis

7. Slovakia Cancer Therapeutics Market Analysis – by Therapy Types

7.1 Slovakia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types

8. Slovakia Cancer Therapeutics Market Analysis – by Indications

8.1 Slovakia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

9. Slovakia Cancer Therapeutics Market Analysis – by Distribution Channel

9.1 Slovakia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis by Key Players

10.1 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.2 Partnerships and Collaborations

11.2 Other Developments

12. Company Profiles

12.1 Bristol-Myers Squibb Co

12.1. 1 Key Facts

12.1. 2 Business Description

12.1. 3 Products and Services

12.1. 4 Financial Overview

12.1. 5 SWOT Analysis

12.1. 6 Key Developments

12.2 AbbVie Inc

12.2. 1 Key Facts

12.2. 2 Business Description

12.2. 3 Products and Services

12.2. 4 Financial Overview

12.2. 5 SWOT Analysis

12.2. 6 Key Developments

12.3 Johnson & Johnson

12.3. 1 Key Facts

12.3. 2 Business Description

12.3. 3 Products and Services

12.3. 4 Financial Overview

12.3. 5 SWOT Analysis

12.3. 6 Key Developments

12.4 F. Hoffmann-La Roche Ltd

12.4. 1 Key Facts

12.4. 2 Business Description

12.4. 3 Products and Services

12.4. 4 Financial Overview

12.4. 5 SWOT Analysis

12.4. 6 Key Developments

12.5 Pfizer Inc

12.5. 1 Key Facts

12.5. 2 Business Description

12.5. 3 Products and Services

12.5. 4 Financial Overview

12.5. 5 SWOT Analysis

12.5. 6 Key Developments

12.6 AstraZeneca Plc

12.6. 1 Key Facts

12.6. 2 Business Description

12.6. 3 Products and Services

12.6. 4 Financial Overview

12.6. 5 SWOT Analysis

12.6. 6 Key Developments

12.7 Merck KGaA

12.7. 1 Key Facts

12.7. 2 Business Description

12.7. 3 Products and Services

12.7. 4 Financial Overview

12.7. 5 SWOT Analysis

12.7. 6 Key Developments

12.8 Novartis AG

12.8. 1 Key Facts

12.8. 2 Business Description

12.8. 3 Products and Services

12.8. 4 Financial Overview

12.8. 5 SWOT Analysis

12.8. 6 Key Developments

12.9 Astellas Pharma Inc

12.9. 1 Key Facts

12.9. 2 Business Description

12.9. 3 Products and Services

12.9. 4 Financial Overview

12.9. 5 SWOT Analysis

12.9. 6 Key Developments

12.10 Eli Lilly and Co

12.10. 1 Key Facts

12.10. 2 Business Description

12.10. 3 Products and Services

12.10. 4 Financial Overview

12.10. 5 SWOT Analysis

12.10. 6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

언급된 주요 기업들

TABLE OF COMPANIES

1. Bristol-Myers Squibb Co

2. AbbVie Inc

3. Johnson & Johnson

4. F. Hoffmann-La Roche Ltd

5. Pfizer Inc

6. AstraZeneca Plc

7. Merck KGaA

8. Novartis AG

9. Astellas Pharma Inc

10. Eli Lilly and Co

표 목록 (Tables)

TABLE OF TABLES

Table 1. Slovakia Cancer Therapeutics Market Segmentation

Table 2. List of Vendors

Table 3. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)

Table 4. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 5. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types

Table 6. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types

Table 7. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 8. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 9. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 10. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 11. List of Abbreviations

그림 목록 (Figures)

TABLE OF FIGURES

Figure 1. Impact Analysis of Drivers and Restraints

Figure 2. Slovakia Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031

Figure 3. Heat Map Analysis by Key Players

Figure 4. Company Positioning and Concentration